Genmab (OTCPK:GNMSF) prices its IPO of 28.5M (from 27.8M) American Depositary Shares (ADSs) at $17.75 per ADS, each representing 1/10 of an ordinary share.
Underwriters over-allotment is an additional ~4.3M ADSs.
Trading commences July 18.
The ticker will change to “GMAB” when the ordinary shares underlying the ADSs start trading in Copenhagen, expected to be July 23.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.